No apparent effect of cidofovir in epidermodysplasia verruciformis

J Clin Virol. 2000 Feb;16(1):55-7. doi: 10.1016/s1386-6532(99)00069-4.

Abstract

This paper reports the failure of a patient suffering from Epidermodysplasia verruciformis, characterised by widespread infection of the skin with human papillomaviruses, to respond to topical and systemic treatment with the antiviral agent, Cidofovir, despite its previously demonstrated effectiveness against a range of different papillomavirus-associated conditions.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Cidofovir
  • Cytosine / analogs & derivatives*
  • Cytosine / therapeutic use
  • Epidermodysplasia Verruciformis / drug therapy*
  • Epidermodysplasia Verruciformis / virology
  • Humans
  • Male
  • Organophosphonates*
  • Organophosphorus Compounds / therapeutic use*
  • Papillomaviridae*
  • Treatment Failure

Substances

  • Antiviral Agents
  • Organophosphonates
  • Organophosphorus Compounds
  • Cytosine
  • Cidofovir